Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Geisler, J. G.
Right arrow Articles by Soeller, W. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Geisler, J. G.
Right arrow Articles by Soeller, W. C.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes 51:2158-2169, 2002
© 2002 by the American Diabetes Association, Inc.

Estrogen Can Prevent or Reverse Obesity and Diabetes in Mice Expressing Human Islet Amyloid Polypeptide

John G. Geisler1, Walter Zawalich1, Kathleen Zawalich1, Jonathan R.T. Lakey2, Hans Stukenbrok3, Anthony J. Milici3, and Walter C. Soeller3

1 Yale University, New Haven, Connecticut
2 University of Alberta, Edmonton, Canada
3 Pfizer Global Research and Development, Pfizer Inc., Groton, Connecticut

Type 2 diabetes is characterized by loss of ß-cell mass and concomitant deposition of amyloid derived from islet amyloid polypeptide (IAPP). Previously we have shown that expression of human IAPP (huIAPP) in islets of transgenic mice results in either a rapid onset of hyperglycemia in mice homozygous for the huIAPP transgene on a lean background (FVB/N) or a gradual hyperglycemia in mice hemizygous for the huIAPP transgene on an obese background (Avy/A). In both strains, only the males routinely develop diabetes. To investigate this sexual dimorphism, we treated young prediabetic Avy/A mice transgenic for huIAPP (huIAPP-Avy) with 17ß-estradiol (E2). The treatment completely blocked the progression to hyperglycemia but also prevented the associated weight gain in these mice. Immunohistochemistry of pancreatic sections demonstrated normal islet morphology with no apparent deposition of islet amyloid. E2 treatment of 1-year-old huIAPP-Avy diabetic males rapidly reverses obesity and hyperglycemia. To determine the effects of E2 in a nonobese model, we also treated prediabetic, ad libitum–fed and pair-fed Lean-huIAPP transgenic males. E2 completely blocked the progression to hyperglycemia with no significant effect on body weight. Pancreatic insulin content and plasma insulin concentration of Lean-huIAPP transgenic mice increased in a dose-dependent manner. We demonstrated the presence of estrogen receptor (ER)-{alpha} mRNA in mouse and human islets. By also confirming the presence of ER-{alpha} protein in islets, we discovered a novel 58-kDa ER-{alpha} isoform in mice and a 52-kDa isoform in humans, in the absence of the classic 67-kDa protein found in most tissues of both species. The demonstrated presence of ER-{alpha} in mouse and human islets is consistent with a direct effect on islet function. We conclude that exogenous E2 administered to male mice may block human IAPP-mediated ß-cell loss both by direct action on ß-cells and by decreasing insulin demand through inhibition of weight gain or increasing insulin action.



Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Endocr. Rev.Home page
R. H. Straub
The Complex Role of Estrogens in Inflammation
Endocr. Rev., August 1, 2007; 28(5): 521 - 574.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. Satoh, C. M. Matter, H. Ogita, K. Takeshita, C.-Y. Wang, G. W. Dorn II, and J. K. Liao
Inhibition of Apoptosis-Regulated Signaling Kinase-1 and Prevention of Congestive Heart Failure by Estrogen
Circulation, June 26, 2007; 115(25): 3197 - 3204.
[Abstract] [Full Text] [PDF]


Home page
J EndocrinolHome page
M Fraenkel, J Caloyeras, S-G Ren, and S Melmed
Sex-steroid milieu determines diabetes rescue in pttg-null mice.
J. Endocrinol., June 1, 2006; 189(3): 519 - 528.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
S. Tang, S. L. Tan, S. K. Ramadoss, A. P. Kumar, M.-H. E. Tang, and V. B. Bajic
Computational method for discovery of estrogen responsive genes
Nucleic Acids Res., December 1, 2004; 32(21): 6212 - 6217.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
A. E. Butler, J. Janson, W. C. Soeller, and P. C. Butler
Increased {beta}-Cell Apoptosis Prevents Adaptive Increase in {beta}-Cell Mass in Mouse Model of Type 2 Diabetes: Evidence for Role of Islet Amyloid Formation Rather Than Direct Action of Amyloid
Diabetes, September 1, 2003; 52(9): 2304 - 2314.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2002 by the American Diabetes Association.